Skip to main content

MARSHALL WACE, LLP

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1318757 LONDON, X0

Position in SPRY

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$843,197
-$79,646 QoQ
Shares Held
105,006
+32.6% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2021
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $2,766,756,129 across 280 Biotechnology names. SPRY ranks #199 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SPRY

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $843,197 105,006
2025-12-31 $922,843 79,214
2025-09-30 $1,983,065 197,320
2025-06-30 $696,498 39,914
2025-03-31 $1,970,467 156,635
2024-12-31 $558,157 52,906
2024-09-30 $1,129,245 77,879
2023-06-30 $499,960 74,621
2023-03-31 $256,676 39,428
2022-12-31 $273,053 32,011
2021-09-30 $2,750,158 275,567